I am interested in the study of neuropathology, biomarkers and clinical features of neurodegenerative diseases. My work focuses on the application of neuroimaging techniques, such as PET and MRI, to describe progressive brain changes in dementia and related disorders, in order to identify early diagnostic and prognostic markers.
Magnetic resonance imaging (MRI)
Positron Emission Tomography (PET)
No collaborators listed
Associated News Items
Malpetti M, Kievit RA, Passamonti L, Jones PS, Tsvetanov KA, Rittman T, Mak E, Nicastro N, Bevan-Jones WR, Su L, Hong YT, Fryer TD, Aigbirhio FI, O'Brien JT, Rowe JB (2020), “Microglial activation and tau burden predict cognitive decline in Alzheimer's disease” Brain 143(5):1588-1602